 Congenital anomalies children patients chemotherapy cancer childhood adolescence BACKGROUND Many patients childhood cancer regimens mutagenic chemotherapeutic agents treatment childhood adolescence children METHODS effect chemotherapy cancer childhood adolescence outcome subsequent pregnancies records men women pediatric cancer questionnaire patients pregnancies patients chemotherapy part treatment cancer patients wives patients pregnancies weeks gestation former patients total live-born stillborn children RESULTS frequency congenital anomalies percent live-born children women percent live-born children men Structural congenital cardiac defects percent children women dactinomycin percent children multicenter survey fetal anomalies relation number mutagens cumulative dose agent frequency congenital anomalies children CONCLUSIONS data treatment children adolescents mutagenic chemotherapeutic agents dose frequency congenital anomalies children former patients possible adverse effect dactinomycin children patients study